ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL EYE INSTITUTE

Translational Core for Therapeutic and Diagnostic Development

Completed
Institution
UNIVERSITY OF ILLINOIS AT CHICAGO, IL
Principal investigator
James Jason Mcanany
Funding
$100K
Duration
1997–2026
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY: TRANSLATIONAL CORE FOR THERAPEUTIC AND DIAGNOSTIC DEVELOPMENT The Translational Core for Therapeutic and Diagnostic Development (TCTDD) will enhance the research programs of a growing number of R01 funded investigators engaged in basic science research by providing powerful new data science and high throughput data analysis support. Currently, NEI R01 grants supported by this P30 grant are engaged in basic biomedical research (T0 research) with explicitly stated goals of translation of research findings for new methods of diagnosis, treatment, and prevention of eye diseases (T1 research). The TCTDD core will provide Data Science and Artificial Intelligence (AI) services for pre-processing, analysis and visualization of basic research data (molecular, cellular and imaging) to provide deeper mechanistic insights and synergistic opportunities for moving towards translational research (Aim 1). The TCTDD core will also provide technology-driven, automated services to bolster the research throughput for generating high quality, rigorous research data which will expand the breadth and depth of basic science research while accelerating related translational research (Aim 2). The long-term goal is to accelerate discoveries that easily transit from bench-to- bedside.

LOADING MOONBASE SCORE

NATIONAL EYE INSTITUTEP30ZEY1-VSNthroughputtranslationaldiagnosticbasicresearch dataresearch aimscience researchbasic science

Questions for UNIVERSITY OF ILLINOIS AT CHICAGO

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.